Title:
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
Document Type and Number:
WIPO Patent Application WO/2022/143969
Kind Code:
A1
Abstract:
The present invention belongs to the technical field of medicines, and particularly relates to a pharmaceutical composition for preventing and/or treating cancers. In particular, a pharmaceutical composition comprising a CDK4/6 inhibitor compound as represented by formula (I) or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent or a pharmaceutically acceptable salt thereof at a fixed ratio or a fixed dose, the use of the pharmaceutical composition in the preparation of a drug for preventing and/or treating cancers, and a kit comprising the pharmaceutical composition.
More Like This:
| JP2013511571 | Imidazo-pyrazole as a GPR119 inhibitor |
| JP7450610 | Activation of pyruvate kinase R |
| WO2003002058 | BONE ANABOLIC COMPOUNDS AND METHODS OF USE |
Inventors:
XU YANJUN (CN)
LI JIAKUI (CN)
LI JIAKUI (CN)
Application Number:
PCT/CN2021/143483
Publication Date:
July 07, 2022
Filing Date:
December 31, 2021
Export Citation:
Assignee:
XUANZHU BIOPHARMACEUTICAL CO LTD (CN)
SHANDONG XUANZHU PHARMA CO LTD (CN)
SHANDONG XUANZHU PHARMA CO LTD (CN)
International Classes:
A61K31/506; A61P35/00; A61P35/04
Domestic Patent References:
| WO2019144759A1 | 2019-08-01 | |||
| WO2015101293A1 | 2015-07-09 | |||
| WO2020224609A1 | 2020-11-12 |
Foreign References:
| CN110092775A | 2019-08-06 | |||
| CN112010839A | 2020-12-01 |
Download PDF: